| 2021 | | Effectiveness and drug retention of biologic disease modifying antirheumatic drugs in Korean patients with late onset ankylosing spondylitis | 김현아 |
| 2021 | | Effectiveness and safety of biologic and targeted synthetic disease-modifying anti-rheumatic drugs in elderly patients with rheumatoid arthritis: Real-world data from the KOBIO registry | 김현아 |
| 2023 | | Effects of COVID-19 and Influenza Vaccination on Rheumatic Diseases: Results From a Survey of Patient-Reported Outcomes After Vaccination | 김지원, 김현아, 서창희, 예영민, 정주양 |
| 2022 | | Effects of RETN polymorphisms on treatment response in rheumatoid arthritis patients receiving TNF-α inhibitors and utilization of machine-learning algorithms | 김현아, 정주양 |
| 2018 | | Effects of risk factors for and components of metabolic syndrome on the quality of life of patients with systemic lupus erythematosus: a structural equation modeling approach | 김현아 |
| 2019 | | Effects of tapering tumor necrosis factor inhibitor on the achievement of inactive disease in patients with axial spondyloarthritis: a nationwide cohort study | 김현아 |
| 2023 | | Efficacy and drug retention of tofacitinib in rheumatoid arthritis: from the nationwide Korean College of Rheumatology Biologics registry | 김지원, 김현아, 서창희, 정주양 |
| 2020 | | Efficacy and Safety of Rituximab in Korean Patients with Refractory Inflammatory Myopathies | 서창희 |
| 2017 | | Efficacy and Safety of Switching from Innovator Rituximab to Biosimilar CT-P10 Compared with Continued Treatment with CT-P10: Results of a 56-Week Open-Label Study in Patients with Rheumatoid Arthritis | 서창희 |
| 2019 | | Efficacy and safety of switching from rituximab to biosimilar CT-P10 in rheumatoid arthritis: 72-week data from a randomized Phase 3 trial | 서창희 |
| 2016 | | Efficacy of tocilizumab therapy in Korean patients with adult-onset Still's disease: a multicentre retrospective study of 22 cases | 김현아 |
| 2017 | | Efficacy, Safety and Pharmacokinetics of Up to Two Courses of the Rituximab Biosimilar CT-P10 Versus Innovator Rituximab in Patients with Rheumatoid Arthritis: Results up to Week 72 of a Phase I Randomized Controlled Trial | 서창희 |
| 2016 | | Elevated high-mobility group B1 levels in active adult-onset Still's disease associated with systemic score and skin rash | 김현아, 서창희, 손성향, 정주양 |
| 2015 | | Elevated Salivary Alpha-Amylase Level, Association Between Depression and Disease Activity, and Stress as a Predictor of Disease Flare in Systemic Lupus Erythematosus: A Prospective Case-Control Study. | 김현아, 서창희, 정주양 |
| 2021 | | Eubacterium rectale Attenuates HSV-1 Induced Systemic Inflammation in Mice by Inhibiting CD83 | 김현아, 서창희, 손성향, 유혜명, 정주양 |
| 2019 | | Evaluation of factors affecting the levels of physical activity in patients with rheumatoid arthritis: a cross-sectional study | 부선주, 서창희, 정주양 |
| 2018 | | Factors associated with quality of life and functional disability among rheumatoid arthritis patients treated with disease-modifying anti-rheumatic drugs for at least 6 months | 서창희 |
| 2015 | | High-density genotyping of immune loci in Koreans and Europeans identifies eight new rheumatoid arthritis risk loci. | 서창희 |
| 2016 | | High-density genotyping of immune-related loci identifies new SLE risk variants in individuals with Asian ancestry | 서창희 |
| 2017 | | Highly Expression of CD11b and CD32 on Peripheral Blood Mononuclear Cells from Patients with Adult-Onset Still's Disease | 김현아, 서창희, 손성향, 정주양 |
| 2003 | | Horner's syndrome as an initial manifestation of Takayasu's arteritis. | 박해심, 서유진, 서창희, 최정희 |
| 2016 | | Hyponatremia in patients with systemic lupus erythematosus | 박세진, 서창희 |
| 2017 | | Identifying fibromyalgia subgroups using cluster analysis: Relationships with clinical variables | 김현아 |
| 2020 | | Impact of immunogenicity on efficacy and tolerability of tumour necrosis factor inhibitors: pooled analysis of biosimilar studies in rheumatoid arthritis | 서창희 |
| 2004 | | Increased levels of IgG to cytokeratin 19 in sera of patients with toluene diisocyanate-induced asthma. | 김승현, 남동호, 박해심, 서창희 |
| 2012 | | Induction of remission is difficult due to frequent relapse during tapering steroids in Korean patients with polymyalgia rheumatica | 김현아, 서창희 |
| 2010 | | Interleukin 6 gene polymorphisms are associated with systemic lupus erythematosus in Koreans. | 김승현, 김현아, 박해심, 서창희 |
| 2017 | | Knowledge and perception of cardiovascular disease risk among patients with rheumatoid arthritis | 부선주, 서창희 |
| 2012 | | Korean Observational Study Network for Arthritis (KORONA): establishment of a prospective multicenter cohort for rheumatoid arthritis in South Korea | 김현아, 서창희 |
| 2015 | | Korean versions of the Perceived Stress Scale (PSS-14, 10 and 4): psychometric evaluation in patients with chronic disease. | 서창희, 이은현, 정주양 |
| 2006 | | Lack of an association between a newly identified promoter polymorphism (-1702G > A) of the leukotriene C4 synthase gene and aspirin-intolerant asthma in a Korean population. | 김승현, 남동호, 박해심, 서창희 |
| 2005 | | Leukotriene-related gene polymorphisms in patients with aspirin-intolerant urticaria and aspirin-intolerant asthma: differing contributions of ALOX5 polymorphism in Korean population. | 김승현, 남동호, 박해심, 서창희 |
| 2019 | | Long-Term Efficacy and Safety of Biosimilar CT-P10 Versus Innovator Rituximab in Rheumatoid Arthritis: 48-Week Results from a Randomized Phase III Trial | 서창희 |
| 2019 | | Long-term efficacy, safety and immunogenicity in patients with rheumatoid arthritis continuing on an etanercept biosimilar (LBEC0101) or switching from reference etanercept to LBEC0101: an open-label extension of a phase III multicentre, randomised, double-blind, parallel-group study | 서창희 |
| 2021 | | Meta-analysis of 208370 East Asians identifies 113 susceptibility loci for systemic lupus erythematosus | 서창희 |
| 2019 | | Mindfulness-based cognitive therapy in Korean patients with systemic lupus erythematosus: A pilot study | 김현아, 서창희, 정주양, 조선미 |
| 2019 | | Neutrophil Extracellular Traps May Contribute to the Pathogenesis in Adult-onset Still Disease | 권지은, 김현아, 서창희, 정주양, 최용준, 한재호 |
| 2019 | | Neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio are associated with disease activity in polymyalgia rheumatica | 김현아, 서창희, 정주양 |
| 2012 | | Nonsteroidal antiinflammatory drugs (NSAID) versus NSAID with hydroxychloroquine in treatment of chemotherapy-related arthropathy: open-label multicenter pilot study | 김현아, 서창희 |
| 2020 | | Obesity increases the incidence of new-onset lupus nephritis and organ damage during follow-up in patients with systemic lupus erythematosus | 김현아 |
| 2018 | | Off-label use of tocilizumab to treat non-juvenile idiopathic arthritis in pediatric rheumatic patients: a literature review | 김현아, 서창희, 정주양 |
| 2018 | | Outcome and predictors of renal survival in patients with lupus nephritis: Comparison between cyclophosphamide and mycophenolate mofetil | 김현아, 서창희 |
| 2016 | | Perceived and actual risk of cardiovascular disease in patients with rheumatoid arthritis in Korea: A cross-sectional study | 부선주, 서창희, 정주양 |
| 2018 | | Polyamine patterns in plasma of patients with systemic lupus erythematosus and fever | 김현아, 서창희, 이광, 정주양 |
| 2005 | | Polymorphism of tandem repeat in promoter of 5-lipoxygenase in ASA-intolerant asthma: a positive association with airway hyperresponsiveness. | 김승현, 남동호, 박해심, 서창희 |
| 2005 | | Polymorphisms of high-affinity IgE receptor and histamine-related genes in patients with ASA-induced urticaria/angioedema. | 김승현, 남동호, 박해심, 서창희 |
| 2019 | | Polymorphisms of MFGE8 are associated with susceptibility and clinical manifestations through gene expression modulation in Koreans with systemic lupus erythematosus | 김현아, 서창희, 정주양 |
| 2016 | | Polymorphisms of the TRPV2 and TRPV3 genes associated with fibromyalgia in a Korean population | 김현아 |
| 2015 | | Reactive hemophagocytic syndrome in adult-onset Still disease: clinical features, predictive factors, and prognosis in 21 patients. | 김현아, 서창희, 정주양 |
| 2020 | | Retention Rate and Safety of Biosimilar CT-P13 in Rheumatoid Arthritis: Data from the Korean College of Rheumatology Biologics Registry | 김현아 |
| 2015 | | Rheumatoid arthritis patients fulfilling Korean National Health Insurance reimbursement guidelines for anti-tumor necrosis factor-α treatment and comparison to other guidelines. | 서창희 |
| 2005 | | Rheumatoid factor is a marker of disease severity in Korean rheumatoid arthritis. | 남동호, 박해심, 서창희, 조재현 |
| 2015 | | Role of bone scan in the assessment of polymyositis/dermatomyositis. | 김현아, 서창희, 안영실, 정주양 |
| 2016 | | Safety of Resuming Tumor Necrosis Factor Inhibitors in Ankylosing Spondylitis Patients Concomitant with the Treatment of Active Tuberculosis: A Retrospective Nationwide Registry of the Korean Society of Spondyloarthritis Research | 서창희, 정주양 |
| 2016 | | Salivary cortisol levels, but not salivary alpha-amylase levels, are elevated in patients with rheumatoid arthritis irrespective of depression | 김현아, 박샛별, 서창희 |
| 2021 | | Salivary immunoglobulin gamma-3 chain c is a promising noninvasive biomarker for systemic lupus erythematosus | 김현아, 서창희, 정주양 |
| 2020 | | Seasonal Variations and Associated Factors of Gout Attacks: a Prospective Multicenter Study in Korea | 김현아, 서창희, 정주양 |
| 2015 | | Seasonality of gout in Korea: a multicenter study. | 김현아, 서창희 |
| 2003 | | Serum cytokine profiles in patients with adult onset Still's disease. | 남동호, 박해심, 서유진, 서창희, 최정희 |
| 2017 | | Serum Levels of Interleukin 33 and Soluble ST2 Are Associated with the Extent of Disease Activity and Cutaneous Manifestations in Patients with Active Adult-onset Still's Disease | 권지은, 김현아, 서창희, 임현이, 정주양, 한재호 |
